3/31/2014 9:24:50 AM
March 31 2014, Uppsala, Sweden: Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today that it has appointed Tekon Biotech as exclusive distributor of its nanoliter-scale immunoassay platform Gyrolab™ xP in China, Taiwan & Hong Kong. Tekon Biotech is a leading distributor to pharmaceutical, biotechnology and academic laboratories.
Gyros’ immunoassay platform (www.gyros.com) is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands. The platform comprises Gyrolab xP workstation, control and evaluation software, and the unique microfluidic Gyrolab Bioaffy CDs in which immunoassay steps are integrated and run at nanoliter scale.
“We are impressed with Tekon’s reputation for service and technical support in the region, and with a customer base including all major pharmaceutical and biotechnology companies in China, as well as the top 50 universities, Tekon is an ideal partner,” said Dan Calvo, CEO, Gyros AB. “The acceptance of our nanoliter-scale immunoassay platform continues to grow within the global biopharmaceutical industry, and we are delighted that Tekon will be helping to build our network of customers in China, Taiwan and Hong Kong.”
“We are excited to represent Gyros in China," said David Hadfield, CEO, Tekon Biotech in Shanghai. “With the tremendous growth in Biologics in China, plus increased demand for PK/PD and ADA testing, we see great potential for the Gyrolab platform and it’s advances in miniaturized, automated immunoassays.”
Zyme Communications Ltd
Tel: +44 (0) 7787 502 947
About Gyros AB (www.gyros.com)
Gyros AB is the world leader in utilization of microfluidic technologies to miniaturize and automate immunoassays. The Gyros™ immunoassay platform increases productivity and efficiency during development of biotherapeutics and vaccines, saving time and labor. Major biopharmaceutical companies and their service providers utilize the Gyros platform to boost time-critical workflows and meet increasing regulatory demands.
Spanning the entire spectrum of immunoassays, the platform reduces the time to result significantly. Faster development times, and unattended running of assays at nanoliter scale, reduce labor and sample. The ease of assay transfer between sites and from development to regulated environments is unsurpassed in the industry.
The company is based in Uppsala, Sweden and has regional sales and support offices in the USA and Europe, and a growing network of distributors in Asia Pacific.
About Tekon Biotech (www.tekontech.com)
Tekon Biotech, founded in 1988, sells and supports a broad range of technologies in the China life sciences market. Tekon's customers include all major pharmaceutical and biotech companies plus the top 50 universities. Tekon is headquartered in Shanghai with offices in Hong Kong and Taipei. Tekon Biotech takes pride in providing the best service and technical support. For more information, visit www.tekontech.com
Help employers find you! Check out all the jobs and post your resume.
comments powered by